I wonder if sleep apnea diagnoses will decrease with the increasing use of GLP-1s?
Zepbound is FDA-approved for OSA.
Zepbound is FDA-approved for OSA.
I wonder if we'll discover that there's actually an endemic deficiency in endogenous GLP-1 production due to some other cause? The usual suspects of environmental contamination or subclinical infection, perhaps.